Journal of International Psychiatry

Objective To analyze the effect of escitalopram treatment on female patients with burning mouth syndrome. Methods Random number table method was used to group 91 female patients with burning mouth syndrome in our hospital. The two groups were given oral vitamin B treatment. Based on this, 45 patients in the control group were increased in psychological therapy, and 46 patients in the observation group were increased based on the control group. Oral treatment of escitalopram, comparison of anxiety and depression, cytokine levels, changes in mental health, quality of life and clinical efficacy of the two groups of patients after treatment. Results After treatment, the SF-36 score and total effective rate of the observation group were higher than those of the control group, and the levels of IL-6, TNF-α, and SDS, SAS, and SCL-90 were lower than those of the control group (P <0.05). Conclusion The application of escitalopram on the basis of conventional treatment can effectively relieve the anxiety and depression of female patients with burning mouth syndrome, regulate the level of cytokines, improve the mental health and quality of life of patients, and enhance the therapeutic effect.

escitalopram; female burning mouth syndrome; anxiety and depression; Cytokine; mental health